SLC38A7 and rheumatoid arthritis: Raposo et al. found that using the amino acid transport inhibitor 2-(methylamino) isobutyric acid could attenuate the severity of arthritis in diseased animals [25], suggesting that the amino acids and their transporters might be the key factor in RA pathogenesis.